img

Global NK Cells Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global NK Cells Market Insights, Forecast to 2034

Global NK Cells market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, NK Cells industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, NK Cells key manufacturers include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc. Chipscreen Biosciences, Affimed NV, Altor BioScience are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of NK Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole NK Cells market and estimated to attract more attentions from industry insiders and investors.
NK Cells can be divided into Mogamulizumab, Lorvotuzumab Mertansine and Others,, etc. Mogamulizumab is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
NK Cells is widely used in various fields, such as Cancer, Cardiovascular Diseases and Others,, etc. Cancer provides greatest supports to the NK Cells industry development. In 2022, global % sales of NK Cells went into Cancer filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global NK Cells market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global NK Cells market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Fortress Biotech
Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application


Cancer
Cardiovascular Diseases
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ NK Cells plant distribution, commercial date of NK Cells, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, NK Cells introduction, etc. NK Cells Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of NK Cells
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 NK Cells Product Introduction
1.2 Market by Type
1.2.1 Global NK Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market by Application
1.3.1 Global NK Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global NK Cells Sales Estimates and Forecasts 2018-2029
2.2 Global NK Cells Revenue by Region
2.2.1 Global NK Cells Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global NK Cells Revenue by Region (2018-2024)
2.2.3 Global NK Cells Revenue by Region (2024-2029)
2.2.4 Global NK Cells Revenue Market Share by Region (2018-2029)
2.3 Global NK Cells Sales Estimates and Forecasts 2018-2029
2.4 Global NK Cells Sales by Region
2.4.1 Global NK Cells Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global NK Cells Sales by Region (2018-2024)
2.4.3 Global NK Cells Sales by Region (2024-2029)
2.4.4 Global NK Cells Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global NK Cells Sales by Manufacturers
3.1.1 Global NK Cells Sales by Manufacturers (2018-2024)
3.1.2 Global NK Cells Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of NK Cells in 2022
3.2 Global NK Cells Revenue by Manufacturers
3.2.1 Global NK Cells Revenue by Manufacturers (2018-2024)
3.2.2 Global NK Cells Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by NK Cells Revenue in 2022
3.3 Global Key Players of NK Cells, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global NK Cells Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of NK Cells, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of NK Cells, Product Offered and Application
3.8 Global Key Manufacturers of NK Cells, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global NK Cells Sales by Type
4.1.1 Global NK Cells Historical Sales by Type (2018-2024)
4.1.2 Global NK Cells Forecasted Sales by Type (2024-2029)
4.1.3 Global NK Cells Sales Market Share by Type (2018-2029)
4.2 Global NK Cells Revenue by Type
4.2.1 Global NK Cells Historical Revenue by Type (2018-2024)
4.2.2 Global NK Cells Forecasted Revenue by Type (2024-2029)
4.2.3 Global NK Cells Revenue Market Share by Type (2018-2029)
4.3 Global NK Cells Price by Type
4.3.1 Global NK Cells Price by Type (2018-2024)
4.3.2 Global NK Cells Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global NK Cells Sales by Application
5.1.1 Global NK Cells Historical Sales by Application (2018-2024)
5.1.2 Global NK Cells Forecasted Sales by Application (2024-2029)
5.1.3 Global NK Cells Sales Market Share by Application (2018-2029)
5.2 Global NK Cells Revenue by Application
5.2.1 Global NK Cells Historical Revenue by Application (2018-2024)
5.2.2 Global NK Cells Forecasted Revenue by Application (2024-2029)
5.2.3 Global NK Cells Revenue Market Share by Application (2018-2029)
5.3 Global NK Cells Price by Application
5.3.1 Global NK Cells Price by Application (2018-2024)
5.3.2 Global NK Cells Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada NK Cells Market Size by Type
6.1.1 US & Canada NK Cells Sales by Type (2018-2029)
6.1.2 US & Canada NK Cells Revenue by Type (2018-2029)
6.2 US & Canada NK Cells Market Size by Application
6.2.1 US & Canada NK Cells Sales by Application (2018-2029)
6.2.2 US & Canada NK Cells Revenue by Application (2018-2029)
6.3 US & Canada NK Cells Market Size by Country
6.3.1 US & Canada NK Cells Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada NK Cells Sales by Country (2018-2029)
6.3.3 US & Canada NK Cells Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe NK Cells Market Size by Type
7.1.1 Europe NK Cells Sales by Type (2018-2029)
7.1.2 Europe NK Cells Revenue by Type (2018-2029)
7.2 Europe NK Cells Market Size by Application
7.2.1 Europe NK Cells Sales by Application (2018-2029)
7.2.2 Europe NK Cells Revenue by Application (2018-2029)
7.3 Europe NK Cells Market Size by Country
7.3.1 Europe NK Cells Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe NK Cells Sales by Country (2018-2029)
7.3.3 Europe NK Cells Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China NK Cells Market Size
8.1.1 China NK Cells Sales (2018-2029)
8.1.2 China NK Cells Revenue (2018-2029)
8.2 China NK Cells Market Size by Application
8.2.1 China NK Cells Sales by Application (2018-2029)
8.2.2 China NK Cells Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia NK Cells Market Size by Type
9.1.1 Asia NK Cells Sales by Type (2018-2029)
9.1.2 Asia NK Cells Revenue by Type (2018-2029)
9.2 Asia NK Cells Market Size by Application
9.2.1 Asia NK Cells Sales by Application (2018-2029)
9.2.2 Asia NK Cells Revenue by Application (2018-2029)
9.3 Asia NK Cells Sales by Region
9.3.1 Asia NK Cells Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia NK Cells Revenue by Region (2018-2029)
9.3.3 Asia NK Cells Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America NK Cells Market Size by Type
10.1.1 Middle East, Africa and Latin America NK Cells Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America NK Cells Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America NK Cells Market Size by Application
10.2.1 Middle East, Africa and Latin America NK Cells Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America NK Cells Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America NK Cells Sales by Country
10.3.1 Middle East, Africa and Latin America NK Cells Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America NK Cells Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America NK Cells Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Information
11.1.2 Chipscreen Biosciences Overview
11.1.3 Chipscreen Biosciences NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Chipscreen Biosciences NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Chipscreen Biosciences Recent Developments
11.2 Affimed NV
11.2.1 Affimed NV Company Information
11.2.2 Affimed NV Overview
11.2.3 Affimed NV NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Affimed NV NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Affimed NV Recent Developments
11.3 Altor BioScience
11.3.1 Altor BioScience Company Information
11.3.2 Altor BioScience Overview
11.3.3 Altor BioScience NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Altor BioScience NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Altor BioScience Recent Developments
11.4 Innate Pharma
11.4.1 Innate Pharma Company Information
11.4.2 Innate Pharma Overview
11.4.3 Innate Pharma NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Innate Pharma NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Innate Pharma Recent Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Overview
11.5.3 Takeda NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Takeda NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Takeda Recent Developments
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Information
11.6.2 Sorrento Therapeutics Overview
11.6.3 Sorrento Therapeutics NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sorrento Therapeutics NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sorrento Therapeutics Recent Developments
11.7 NantKwest
11.7.1 NantKwest Company Information
11.7.2 NantKwest Overview
11.7.3 NantKwest NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 NantKwest NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 NantKwest Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Overview
11.8.3 Bristol-Myers Squibb NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bristol-Myers Squibb NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 NKT
11.9.1 NKT Company Information
11.9.2 NKT Overview
11.9.3 NKT NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 NKT NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NKT Recent Developments
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Information
11.10.2 Henry Ford Health Services Overview
11.10.3 Henry Ford Health Services NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Henry Ford Health Services NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Henry Ford Health Services Recent Developments
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Information
11.11.2 Fortress Biotech Overview
11.11.3 Fortress Biotech NK Cells Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Fortress Biotech NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Fortress Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 NK Cells Industry Chain Analysis
12.2 NK Cells Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 NK Cells Production Mode & Process
12.4 NK Cells Sales and Marketing
12.4.1 NK Cells Sales Channels
12.4.2 NK Cells Distributors
12.5 NK Cells Customers
13 Market Dynamics
13.1 NK Cells Industry Trends
13.2 NK Cells Market Drivers
13.3 NK Cells Market Challenges
13.4 NK Cells Market Restraints
14 Key Findings in The Global NK Cells Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global NK Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Mogamulizumab
Table 3. Major Manufacturers of Lorvotuzumab Mertansine
Table 4. Major Manufacturers of Others
Table 5. Global NK Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global NK Cells Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global NK Cells Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global NK Cells Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global NK Cells Revenue Market Share by Region (2018-2024)
Table 10. Global NK Cells Revenue Market Share by Region (2024-2029)
Table 11. Global NK Cells Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global NK Cells Sales by Region (2018-2024) & (g)
Table 13. Global NK Cells Sales by Region (2024-2029) & (g)
Table 14. Global NK Cells Sales Market Share by Region (2018-2024)
Table 15. Global NK Cells Sales Market Share by Region (2024-2029)
Table 16. Global NK Cells Sales by Manufacturers (2018-2024) & (g)
Table 17. Global NK Cells Sales Share by Manufacturers (2018-2024)
Table 18. Global NK Cells Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global NK Cells Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of NK Cells, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. NK Cells Price by Manufacturers 2018-2024 (USD/g)
Table 22. Global NK Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global NK Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cells as of 2022)
Table 24. Global Key Manufacturers of NK Cells, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of NK Cells, Product Offered and Application
Table 26. Global Key Manufacturers of NK Cells, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global NK Cells Sales by Type (2018-2024) & (g)
Table 29. Global NK Cells Sales by Type (2024-2029) & (g)
Table 30. Global NK Cells Sales Share by Type (2018-2024)
Table 31. Global NK Cells Sales Share by Type (2024-2029)
Table 32. Global NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global NK Cells Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global NK Cells Revenue Share by Type (2018-2024)
Table 35. Global NK Cells Revenue Share by Type (2024-2029)
Table 36. NK Cells Price by Type (2018-2024) & (USD/g)
Table 37. Global NK Cells Price Forecast by Type (2024-2029) & (USD/g)
Table 38. Global NK Cells Sales by Application (2018-2024) & (g)
Table 39. Global NK Cells Sales by Application (2024-2029) & (g)
Table 40. Global NK Cells Sales Share by Application (2018-2024)
Table 41. Global NK Cells Sales Share by Application (2024-2029)
Table 42. Global NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global NK Cells Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global NK Cells Revenue Share by Application (2018-2024)
Table 45. Global NK Cells Revenue Share by Application (2024-2029)
Table 46. NK Cells Price by Application (2018-2024) & (USD/g)
Table 47. Global NK Cells Price Forecast by Application (2024-2029) & (USD/g)
Table 48. US & Canada NK Cells Sales by Type (2018-2024) & (g)
Table 49. US & Canada NK Cells Sales by Type (2024-2029) & (g)
Table 50. US & Canada NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada NK Cells Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada NK Cells Sales by Application (2018-2024) & (g)
Table 53. US & Canada NK Cells Sales by Application (2024-2029) & (g)
Table 54. US & Canada NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada NK Cells Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada NK Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada NK Cells Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada NK Cells Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada NK Cells Sales by Country (2018-2024) & (g)
Table 60. US & Canada NK Cells Sales by Country (2024-2029) & (g)
Table 61. Europe NK Cells Sales by Type (2018-2024) & (g)
Table 62. Europe NK Cells Sales by Type (2024-2029) & (g)
Table 63. Europe NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe NK Cells Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe NK Cells Sales by Application (2018-2024) & (g)
Table 66. Europe NK Cells Sales by Application (2024-2029) & (g)
Table 67. Europe NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe NK Cells Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe NK Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe NK Cells Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe NK Cells Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe NK Cells Sales by Country (2018-2024) & (g)
Table 73. Europe NK Cells Sales by Country (2024-2029) & (g)
Table 74. China NK Cells Sales by Type (2018-2024) & (g)
Table 75. China NK Cells Sales by Type (2024-2029) & (g)
Table 76. China NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 77. China NK Cells Revenue by Type (2024-2029) & (US$ Million)
Table 78. China NK Cells Sales by Application (2018-2024) & (g)
Table 79. China NK Cells Sales by Application (2024-2029) & (g)
Table 80. China NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 81. China NK Cells Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia NK Cells Sales by Type (2018-2024) & (g)
Table 83. Asia NK Cells Sales by Type (2024-2029) & (g)
Table 84. Asia NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia NK Cells Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia NK Cells Sales by Application (2018-2024) & (g)
Table 87. Asia NK Cells Sales by Application (2024-2029) & (g)
Table 88. Asia NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia NK Cells Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia NK Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia NK Cells Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia NK Cells Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia NK Cells Sales by Region (2018-2024) & (g)
Table 94. Asia NK Cells Sales by Region (2024-2029) & (g)
Table 95. Middle East, Africa and Latin America NK Cells Sales by Type (2018-2024) & (g)
Table 96. Middle East, Africa and Latin America NK Cells Sales by Type (2024-2029) & (g)
Table 97. Middle East, Africa and Latin America NK Cells Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America NK Cells Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America NK Cells Sales by Application (2018-2024) & (g)
Table 100. Middle East, Africa and Latin America NK Cells Sales by Application (2024-2029) & (g)
Table 101. Middle East, Africa and Latin America NK Cells Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America NK Cells Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America NK Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America NK Cells Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America NK Cells Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America NK Cells Sales by Country (2018-2024) & (g)
Table 107. Middle East, Africa and Latin America NK Cells Sales by Country (2024-2029) & (g)
Table 108. Chipscreen Biosciences Company Information
Table 109. Chipscreen Biosciences Description and Major Businesses
Table 110. Chipscreen Biosciences NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 111. Chipscreen Biosciences NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Chipscreen Biosciences Recent Developments
Table 113. Affimed NV Company Information
Table 114. Affimed NV Description and Major Businesses
Table 115. Affimed NV NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 116. Affimed NV NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Affimed NV Recent Developments
Table 118. Altor BioScience Company Information
Table 119. Altor BioScience Description and Major Businesses
Table 120. Altor BioScience NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 121. Altor BioScience NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Altor BioScience Recent Developments
Table 123. Innate Pharma Company Information
Table 124. Innate Pharma Description and Major Businesses
Table 125. Innate Pharma NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 126. Innate Pharma NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Innate Pharma Recent Developments
Table 128. Takeda Company Information
Table 129. Takeda Description and Major Businesses
Table 130. Takeda NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 131. Takeda NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Takeda Recent Developments
Table 133. Sorrento Therapeutics Company Information
Table 134. Sorrento Therapeutics Description and Major Businesses
Table 135. Sorrento Therapeutics NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 136. Sorrento Therapeutics NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sorrento Therapeutics Recent Developments
Table 138. NantKwest Company Information
Table 139. NantKwest Description and Major Businesses
Table 140. NantKwest NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 141. NantKwest NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. NantKwest Recent Developments
Table 143. Bristol-Myers Squibb Company Information
Table 144. Bristol-Myers Squibb Description and Major Businesses
Table 145. Bristol-Myers Squibb NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 146. Bristol-Myers Squibb NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Bristol-Myers Squibb Recent Developments
Table 148. NKT Company Information
Table 149. NKT Description and Major Businesses
Table 150. NKT NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 151. NKT NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. NKT Recent Developments
Table 153. Henry Ford Health Services Company Information
Table 154. Henry Ford Health Services Description and Major Businesses
Table 155. Henry Ford Health Services NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 156. Henry Ford Health Services NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Henry Ford Health Services Recent Developments
Table 158. Fortress Biotech Company Information
Table 159. Fortress Biotech Description and Major Businesses
Table 160. Fortress Biotech NK Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 161. Fortress Biotech NK Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Fortress Biotech Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. NK Cells Distributors List
Table 166. NK Cells Customers List
Table 167. NK Cells Market Trends
Table 168. NK Cells Market Drivers
Table 169. NK Cells Market Challenges
Table 170. NK Cells Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. NK Cells Product Picture
Figure 2. Global NK Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global NK Cells Market Share by Type in 2022 & 2029
Figure 4. Mogamulizumab Product Picture
Figure 5. Lorvotuzumab Mertansine Product Picture
Figure 6. Others Product Picture
Figure 7. Global NK Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global NK Cells Market Share by Application in 2022 & 2029
Figure 9. Cancer
Figure 10. Cardiovascular Diseases
Figure 11. Others
Figure 12. NK Cells Report Years Considered
Figure 13. Global NK Cells Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global NK Cells Revenue 2018-2029 (US$ Million)
Figure 15. Global NK Cells Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global NK Cells Revenue Market Share by Region (2018-2029)
Figure 17. Global NK Cells Sales 2018-2029 ((g)
Figure 18. Global NK Cells Sales Market Share by Region (2018-2029)
Figure 19. US & Canada NK Cells Sales YoY (2018-2029) & (g)
Figure 20. US & Canada NK Cells Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe NK Cells Sales YoY (2018-2029) & (g)
Figure 22. Europe NK Cells Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China NK Cells Sales YoY (2018-2029) & (g)
Figure 24. China NK Cells Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) NK Cells Sales YoY (2018-2029) & (g)
Figure 26. Asia (excluding China) NK Cells Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America NK Cells Sales YoY (2018-2029) & (g)
Figure 28. Middle East, Africa and Latin America NK Cells Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The NK Cells Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of NK Cells in the World: Market Share by NK Cells Revenue in 2022
Figure 31. Global NK Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global NK Cells Sales Market Share by Type (2018-2029)
Figure 33. Global NK Cells Revenue Market Share by Type (2018-2029)
Figure 34. Global NK Cells Sales Market Share by Application (2018-2029)
Figure 35. Global NK Cells Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada NK Cells Sales Market Share by Type (2018-2029)
Figure 37. US & Canada NK Cells Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada NK Cells Sales Market Share by Application (2018-2029)
Figure 39. US & Canada NK Cells Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada NK Cells Revenue Share by Country (2018-2029)
Figure 41. US & Canada NK Cells Sales Share by Country (2018-2029)
Figure 42. U.S. NK Cells Revenue (2018-2029) & (US$ Million)
Figure 43. Canada NK Cells Revenue (2018-2029) & (US$ Million)
Figure 44. Europe NK Cells Sales Market Share by Type (2018-2029)
Figure 45. Europe NK Cells Revenue Market Share by Type (2018-2029)
Figure 46. Europe NK Cells Sales Market Share by Application (2018-2029)
Figure 47. Europe NK Cells Revenue Market Share by Application (2018-2029)
Figure 48. Europe NK Cells Revenue Share by Country (2018-2029)
Figure 49. Europe NK Cells Sales Share by Country (2018-2029)
Figure 50. Germany NK Cells Revenue (2018-2029) & (US$ Million)
Figure 51. France NK Cells Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. NK Cells Revenue (2018-2029) & (US$ Million)
Figure 53. Italy NK Cells Revenue (2018-2029) & (US$ Million)
Figure 54. Russia NK Cells Revenue (2018-2029) & (US$ Million)
Figure 55. China NK Cells Sales Market Share by Type (2018-2029)
Figure 56. China NK Cells Revenue Market Share by Type (2018-2029)
Figure 57. China NK Cells Sales Market Share by Application (2018-2029)
Figure 58. China NK Cells Revenue Market Share by Application (2018-2029)
Figure 59. Asia NK Cells Sales Market Share by Type (2018-2029)
Figure 60. Asia NK Cells Revenue Market Share by Type (2018-2029)
Figure 61. Asia NK Cells Sales Market Share by Application (2018-2029)
Figure 62. Asia NK Cells Revenue Market Share by Application (2018-2029)
Figure 63. Asia NK Cells Revenue Share by Region (2018-2029)
Figure 64. Asia NK Cells Sales Share by Region (2018-2029)
Figure 65. Japan NK Cells Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea NK Cells Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan NK Cells Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia NK Cells Revenue (2018-2029) & (US$ Million)
Figure 69. India NK Cells Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America NK Cells Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America NK Cells Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America NK Cells Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America NK Cells Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America NK Cells Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America NK Cells Sales Share by Country (2018-2029)
Figure 76. Brazil NK Cells Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico NK Cells Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey NK Cells Revenue (2018-2029) & (US$ Million)
Figure 79. Israel NK Cells Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries NK Cells Revenue (2018-2029) & (US$ Million)
Figure 81. NK Cells Value Chain
Figure 82. NK Cells Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries